| HUM Stock | | | EUR 281.90 1.10 0.39% |
CEO
Mr. Bruce D. Broussard is an President, Chief Executive Officer, Director of Humana Inc. Mr. Broussard was President and CEO, joined Humana in 2011. Under his leadership, Humana has created an integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member experience. With its holistic approach, Humana is dedicated to improving the health of the communities it serves by making it easy for people to achieve their best health. Bruce brings to Humana a wide range of executive leadership experience in publicly traded and private organizations within a variety of healthcare sectors, including oncology, pharmaceuticals, assisted livingsenior housing, home care, physician practice management, surgical centers and dental networks. Prior to joining Humana, Bruce was Chief Executive Officer of McKesson SpecialtyUS Oncology, Inc. US Oncology was purchased by McKesson in December 2010. At US Oncology, Bruce served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board. Bruce plays a leadership role in key business advocacy organizations such as The Business Council and the American Heart Association CEO Roundtable. He is also a member of the Board of Directors of KeyCorporationand the World Economic Forum Health Governors Board. since 2013.
| Age | 61 |
| Tenure | 11 years |
| Phone | 502 580 1000 |
| Web | https://www.humana.com |
Humana Management Efficiency
The company has return on total asset
(ROA) of
0.0611 % which means that it generated a profit of $0.0611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1781 %, meaning that it generated $0.1781 on every $100 dollars invested by stockholders. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.
Humana Inc has accumulated 9.03
B in total debt with debt to equity ratio
(D/E) of 61.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Humana Inc has a current ratio of 1.62, which is within standard range for the sector. Debt can assist Humana until it has trouble settling it off, either with new capital or with free cash flow. So, Humana's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humana Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humana to invest in growth at high rates of return. When we think about Humana's use of debt, we should always consider it together with cash and equity.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. HUMANA INC operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 41600 people. Humana Inc (HUM) is traded on Frankfurt Exchange in Germany and employs 67,100 people.
Management Performance
Humana Inc Leadership Team
Elected by the shareholders, the Humana's board of directors comprises two types of representatives: Humana inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humana. The board's role is to monitor Humana's management team and ensure that shareholders' interests are well served. Humana's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humana's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Ventura, General Counsel | |
| Timothy Wheatley, Segment Retail | |
| Amy Fry, Sr Communications | |
| Susan Diamond, Segment President Home Business | |
| JohnPaul Felter, Chief VP | |
| Bruce Broussard, President CEO, Director | |
| Lisa Stoner, VP Relations | |
| Timothy Huval, Chief Human Resource Officer, Senior Vice President | |
| Sam Deshpande, Senior Vice President Chief Risk Officer | |
| PharmD PharmD, Chief Solutions | |
Humana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Humana a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Humana Stock
When determining whether Humana Inc is a strong investment it is important to analyze Humana's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Humana's
future performance.
For an informed investment choice regarding Humana Stock, refer to the following important reports: Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.